RSV_Symposium_APSR2023_Emblem
Meeting category
Date(s)
18 Nov 2023
Program Language
English
Location
Singapore
Meeting type
In-Person Satellite Symposium
Satellite Symposium Organizer

Spotlight on RSV – A Hidden Epidemic in Older Adults | Satellite Symposium at APSR 2023

Related Enduring Materials

Enduring Materials
The time zone used for this symposium was Singapore Standard Time (SST). 
If you need to convert the times to your timezone, this website might be of interest to you: www.WorldTimeBuddy.com.

                                        
Saturday, 18 November 2023 | Spotlight on RSV – A Hidden Epidemic in Older Adults - 12:30
12:35 SST
RSV Epidemiology in Older Adults, and Implication for Chronic Respiratory Diseases
Ian Wee Liang En, MBBS(Hons), MCRP, MPH
Singapore General Hospital, Singapore
12:50 SST
RSV Prevention – Review of Clinical Trials in the Elderly
Jyoti Somani, MD
National University Hospital, Singapore
13:05 SST
Discussion: RSV, Influenza and COVID Diagnostic and Vaccination – How to Put Them Together?
Jyoti Somani, MD
National University Hospital, Singapore
Ian Wee Liang En, MBBS(Hons), MCRP, MPH
Singapore General Hospital, Singapore
Barnaby Edward Young, MB BChir, PhD
National Centre for Infectious Diseases (NCID), Singapore
Overview
Website_RSV
What's New

About this Symposium

RSV is a common and well-studied virus, known for causing respiratory tract infections in young children. However, the prevalence of RSV is globally underestimated and underappreciated in older adults. RSV-associated acute respiratory infections in older adults account for 336,000 annual hospitalizations and 14,000 deaths per year. Yet these numbers still do not reflect the true burden of RSV, since it usually falls under the umbrella-term “Influenza-like illness” and therefore, specific testing is not always performed.

This burden is particularly high for adults living with high-risk medical conditions, such as heart disease, COPD, asthma, and other conditions that affect overall health. As individuals age, these conditions become more common, and can decrease the body’s normal response to a virus such as RSV. Then, RSV has a more potent effect and increases the risk of complications after infection.

The transmission of viruses such as RSV through long-term care facilities or hospitals is a particular concern due to their fragile patient populations. This means that there is an acute need for effective precautions and preventative measures to combat it’s spread. Similar strategies are currently in place for other respiratory viruses (influenza, COVID-19) and there are several preventative products in development to help decrease RSV-related hospitalizations and deaths.

This symposium aims to raise awareness, promote understanding, and stimulate discussion around the new developments related to RSV. This educational platform reviewed the epidemiology, clinical manifestations, and current treatment plans for RSV while also updating clinicians, public health experts, policymakers, and community representatives about the latest results in RSV vaccine trials and the basic principles of the mRNA vaccine platform. Sharing the most current information on RSV with the world’s health care providers means that we are one step closer to preventing RSV-associated morbidity and mortality.

Program Director
Local Chair
General Information 
Topics of Interest
- Epidemiology (with a focus on local epidemiological patterns where data are available);
- Clinical manifestations;
- Risk factors, and implications of RSV infections in chronic lung diseases;
- Current approaches to treatment;
- Results of recent vaccine trials;
- Basic principles of the mRNA vaccine platform.
Who Should Attend?
- Pulmonologists
- Primary care physicians, including family physicians.
- Infectious disease clinicians, clinical virologists,
- Immunologists, epidemiologists
- Geriatric and palliative care experts
- Vaccine providers and their immunization practice teams.
- Public health officials
- Researchers
- Community representatives
Meeting Objectives
This symposium aims to:

- Raise awareness and educate HCPs about RSV disease burden and clinical management in older adults;

- Facilitate implementation of new preventive options at a national and regional level.
Learning Objectives
After participating in this symposium, participants will be able to:

- Understand the RSV epidemiology, pathology, and risk factors in the older adults;

- Identify accessible diagnostic and therapeutic options and relevant challenges for RSV;

- Increase knowledge about the outpatient and inpatient clinical management and complications resulting from RSV infection in older adults;

- Describe the latest advancement in the development of RSV prevention products and comprehend the efficacy data and safety patterns;

- Increase knowledge of the mRNA vaccine platform, basic principles, and safety profile;

- Plan strategies to better prepare the healthcare system for the rollout and implementation of innovative preventive strategies.
Practical Information 
Congress Venue
The 27th Congress of the Asian Pacific Society of Respiratology took place at Suntec Singapore Convention and Exhibition Centre.

Suntec Convention and Exhibition Centre is the World’s Leading Meetings & Conference Centre located in Singapore. Only 20 minutes from Changi International Airport, Suntec Singapore is conveniently located in the Central Business District and just minutes away from the city’s entertainment and cultural attractions.

Getting to Suntec – https://www.suntecsingapore.com/visit#directions
Congress Materials
Congress materials can be obtained upon registration at the registration desk of the Congress Venue.
Badges
All participants are requested to wear the badge at all times during the congress to ensure admission to the symposium.
Language
The official language of the Congress and Symposium is English.

Translation will not be provided.
Liability and Insurance
By registering for the congress, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Disclaimer
This symposium is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this symposium, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this symposium. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the congress.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official symposium. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the symposium is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Program Director
Local Chair
Support
This symposium is supported by:

The Spotlight on RSV – A Hidden Epidemic in Older Adults | Satellite Symposium at APSR 2023 is supported by an independent educational grant from Moderna.

Moderna was not involved in the development of content or selection of faculty for this educational activity.